NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Author's Avatar
Jun 18, 2021
  • Acquisition establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market